A Pharmacist-Led Oral Chemotherapy Program's Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes

Patients with chronic myeloid leukemia (CML) can be treated with oral tyrosine kinase inhibitors (TKIs). Pharmacist-led oral chemotherapy programs (POCPs) can improve TKI adherence rates, but evaluation of patient satisfaction with such programs is rare. The purpose of this analysis was to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennison, Taylor, Deal, Allison M., Foster, Matthew, Valgus, John, Muluneh, Benyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Research & Scholarship
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017794/
https://www.ncbi.nlm.nih.gov/pubmed/34109047
http://dx.doi.org/10.6004/jadpro.2021.12.2.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017794/
https://www.ncbi.nlm.nih.gov/pubmed/34109047
http://dx.doi.org/10.6004/jadpro.2021.12.2.3

Ejemplares similares